Your computer doesn't have the Flash Player v.8 plugin installed, so this website can't be properly viewed.
For full experience, please download it at Adobe.comBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck & Co., Inc. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed.
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Simply fill in the information below to send your friend an e-mail with information about HPV and GARDASIL.
No personal information (including e-mail addresses) about you or your friend will be collected from this e-mail notification feature offered by Merck & Co., Inc.
Here's the e-mail your friend will receive:
Hi <recipient name>,
As friends it's important that we watch out for each other. That's why I wanted to send you a few of the many facts that I've learned about human papillomavirus (HPV), cervical cancer, and how to help protect yourself from them.
HPV is a common virusI hope this information is helpful, but there's more you should know about HPV and the ways you can help protect yourself. Take a look at this Web site and let's talk soon!
Your friend, <senders name>
*Number represents more than 30 genital HPV types, not just HPV Types 6, 11, 16, and 18.
GARDASIL is the only cervical cancer vaccine that helps protect against 4 types of human papillomavirus (HPV): 2 types that cause 70% of cervical cancer cases, and 2 more types that cause 90% of genital warts cases. GARDASIL is for girls and young women ages 9 to 26.
GARDASIL may not fully protect everyone, and does not prevent all types of cervical cancer, so it’s important to continue routine cervical cancer screenings. GARDASIL does not treat cervical cancer or genital warts. GARDASIL will not protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL is given as 3 injections over 6 months.
Anyone who is allergic to the ingredients of GARDASIL, including those severely allergic to yeast, should not receive the vaccine. GARDASIL is not for women who are pregnant.
The side effects include pain, swelling, itching, bruising, and redness at the injection site, headache, fever, nausea, dizziness, vomiting, and fainting. Sometimes fainting is accompanied by falling with injury, as well as shaking or stiffening and other seizure-like activity. Only a doctor or health care professional can decide if GARDASIL is right for you or your daughter.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Read the Patient Product Information or the Prescribing Information for GARDASIL.
This site is intended only for residents of the United States, its territories, and Puerto Rico.
GARDASIL is a registered trademark of Merck & Co., Inc.
20802636(4)-03/08-GRD